KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Healthpeak Properties (DOC) Other Gross PP&E Adjustments (2016 - 2026)

Healthpeak Properties has reported Other Gross PP&E Adjustments over the past 17 years, most recently at -$21.0 billion for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 3.37% to -$21.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.0 billion through Dec 2025, down 3.37% year-over-year, with the annual reading at -$21.0 billion for FY2025, 3.37% down from the prior year.
  • Other Gross PP&E Adjustments was -$21.0 billion for Q4 2025 at Healthpeak Properties, down from -$20.7 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$12.0 billion in Q1 2021 and troughed at -$21.0 billion in Q4 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$16.7 billion (2022), against an average of -$16.7 billion.
  • Year-over-year, Other Gross PP&E Adjustments grew 11.05% in 2021 and then crashed 49.31% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$13.1 billion in 2021, then decreased by 25.21% to -$16.4 billion in 2022, then decreased by 2.5% to -$16.9 billion in 2023, then decreased by 20.63% to -$20.3 billion in 2024, then decreased by 3.37% to -$21.0 billion in 2025.
  • Per Business Quant, the three most recent readings for DOC's Other Gross PP&E Adjustments are -$21.0 billion (Q4 2025), -$20.7 billion (Q3 2025), and -$20.6 billion (Q2 2025).